ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,595Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 54

$850K Total Retail Price of All Prescriptions

Rank: 4 out of 54

313 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
94% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 313 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 12,740 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

47 is the average number of prescriptions (including refills) per patient, compared to an average of 26.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
FUROSEMIDE 882 775 1 3
LEVOTHYROXINE SODIUM 514 477 2 2
TRAZODONE HCL 499 479 3 10
WARFARIN SODIUM 486 445 4 1
OMEPRAZOLE 473 427 5 9
METOPROLOL TARTRATE 402 359 6 7
GABAPENTIN 366 281 7 16
POTASSIUM CHLORIDE 346 318 8 22
LISINOPRIL 339 308 9 6
METOPROLOL SUCCINATE 267 256 10 14
RISPERIDONE 252 197 11 23
LANTUS 222 188 12 30
AMLODIPINE BESYLATE 220 205 13 4
DONEPEZIL HCL 220 220 13 8
SIMVASTATIN 215 203 15 5
ESCITALOPRAM OXALATE 213 194 16 18
MIRTAZAPINE 212 157 17 11
SERTRALINE HCL 198 196 18 12
PREDNISONE 194 166 19 34
METFORMIN HCL 188 175 20 19
PANTOPRAZOLE SODIUM 179 145 21 33
ATORVASTATIN CALCIUM 162 145 22 15
PRAVASTATIN SODIUM 154 110 23 27
CYMBALTA 153 141 24 26
NAMENDA 148 148 25 13
CITALOPRAM HBR 131 124 26 17
QUETIAPINE FUMARATE 130 129 27 21
DIOVAN 128 122 28 29
TAMSULOSIN HCL 117 115 29 25
LIDODERM 110 105 30 44
ISOSORBIDE MONONITRATE ER 109 90 31 41
LEVETIRACETAM 108 69 32 46
SPIRIVA 107 92 33 51
ATENOLOL 106 96 34 24
TRAMADOL HCL 106 101 34 32
CARVEDILOL 101 87 36 36
CARBIDOPA-LEVODOPA 101 89 36 49
CLOZAPINE 99 99 38 128
CICLOPIROX 99 90 38 128
NOVOLIN N 99 83 38 128
IPRATROPIUM-ALBUTEROL 90 75 41 54
DIVALPROEX SODIUM 88 56 42 28
OLANZAPINE 84 77 43 43
NOVOLOG 84 60 43 66
LEXAPRO 83 75 45 60
ADVAIR DISKUS 82 68 46 42
LABETALOL HCL 78 62 47 115
SPIRONOLACTONE 76 74 48 63
NYSTOP 75 54 49 107
ALBUTEROL SULFATE 71 63 50 84
CLOPIDOGREL 69 62 51 38
OXYCODONE HCL 63 54 S2 52 57
LAMOTRIGINE 62 62 53 101
FAMOTIDINE 61 43 54 55
BACLOFEN 58 24 55 75
AMIODARONE HCL 57 42 56 162
VENLAFAXINE HCL ER 56 30 57 74
TRIAMCINOLONE ACETONIDE 56 55 57 124
HYDROCHLOROTHIAZIDE 54 42 59 20
OXYCONTIN 54 45 S2 59 125
TRAVATAN Z 53 53 61 71
NEXIUM 53 42 61 45
EXELON 53 53 61 63
HYDRALAZINE HCL 52 48 64 58
GLIPIZIDE 51 38 65 47
KETOCONAZOLE 50 46 66 182
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 9, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.